The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drugs for Osteoarthritis Pain-Global Market Insights and Sales Trends 2025
Synopsis
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
The global Drugs for Osteoarthritis Pain market size is expected to reach US$ 13870 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Osteoarthritis Pain in various end use industries. The expanding demands from the Medical Care and Personal Care, are propelling Drugs for Osteoarthritis Pain market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Osteoarthritis Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Osteoarthritis Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Osteoarthritis Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Osteoarthritis Pain covered in this report include Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc.
The global Drugs for Osteoarthritis Pain market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Global Drugs for Osteoarthritis Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Osteoarthritis Pain market, Segment by Type:
Oral
Injection
External
Global Drugs for Osteoarthritis Pain market, by Application
Medical Care
Personal Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drugs for Osteoarthritis Pain companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
The global Drugs for Osteoarthritis Pain market size is expected to reach US$ 13870 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Osteoarthritis Pain in various end use industries. The expanding demands from the Medical Care and Personal Care, are propelling Drugs for Osteoarthritis Pain market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Osteoarthritis Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Osteoarthritis Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Osteoarthritis Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Osteoarthritis Pain covered in this report include Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc.
The global Drugs for Osteoarthritis Pain market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Global Drugs for Osteoarthritis Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Osteoarthritis Pain market, Segment by Type:
Oral
Injection
External
Global Drugs for Osteoarthritis Pain market, by Application
Medical Care
Personal Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drugs for Osteoarthritis Pain companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drugs for Osteoarthritis Pain
1.1 Drugs for Osteoarthritis Pain Market Overview
1.1.1 Drugs for Osteoarthritis Pain Product Scope
1.1.2 Drugs for Osteoarthritis Pain Market Status and Outlook
1.2 Global Drugs for Osteoarthritis Pain Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drugs for Osteoarthritis Pain Market Size by Region (2018-2029)
1.4 Global Drugs for Osteoarthritis Pain Historic Market Size by Region (2018-2023)
1.5 Global Drugs for Osteoarthritis Pain Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drugs for Osteoarthritis Pain Market Size (2018-2029)
1.6.1 North America Drugs for Osteoarthritis Pain Market Size (2018-2029)
1.6.2 Europe Drugs for Osteoarthritis Pain Market Size (2018-2029)
1.6.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2018-2029)
1.6.4 Latin America Drugs for Osteoarthritis Pain Market Size (2018-2029)
1.6.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2018-2029)
2 Drugs for Osteoarthritis Pain Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injection
2.1.3 External
2.2 Global Drugs for Osteoarthritis Pain Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2018-2023)
2.2.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drugs for Osteoarthritis Pain Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drugs for Osteoarthritis Pain Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drugs for Osteoarthritis Pain Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drugs for Osteoarthritis Pain Revenue Breakdown by Type (2018-2029)
3 Drugs for Osteoarthritis Pain Market Overview by Application
3.1 Introduction
3.1.1 Medical Care
3.1.2 Personal Care
3.2 Global Drugs for Osteoarthritis Pain Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2018-2023)
3.2.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drugs for Osteoarthritis Pain Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drugs for Osteoarthritis Pain Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drugs for Osteoarthritis Pain Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drugs for Osteoarthritis Pain Revenue Breakdown by Application (2018-2029)
4 Drugs for Osteoarthritis Pain Competition Analysis by Players
4.1 Global Drugs for Osteoarthritis Pain Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2022)
4.3 Date of Key Players Enter into Drugs for Osteoarthritis Pain Market
4.4 Global Top Players Drugs for Osteoarthritis Pain Headquarters and Area Served
4.5 Key Players Drugs for Osteoarthritis Pain Product Solution and Service
4.6 Competitive Status
4.6.1 Drugs for Osteoarthritis Pain Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Drugs for Osteoarthritis Pain Products, Services and Solutions
5.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Products, Services and Solutions
5.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Products, Services and Solutions
5.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Drugs for Osteoarthritis Pain Products, Services and Solutions
5.4.4 Bayer Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Drugs for Osteoarthritis Pain Products, Services and Solutions
5.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Drugs for Osteoarthritis Pain Products, Services and Solutions
5.6.4 Novartis Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Drugs for Osteoarthritis Pain Products, Services and Solutions
5.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Horizon Pharma
5.8.1 Horizon Pharma Profile
5.8.2 Horizon Pharma Main Business
5.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
5.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.8.5 Horizon Pharma Recent Developments
5.9 Abbott
5.9.1 Abbott Profile
5.9.2 Abbott Main Business
5.9.3 Abbott Drugs for Osteoarthritis Pain Products, Services and Solutions
5.9.4 Abbott Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.9.5 Abbott Recent Developments
5.10 Mylan
5.10.1 Mylan Profile
5.10.2 Mylan Main Business
5.10.3 Mylan Drugs for Osteoarthritis Pain Products, Services and Solutions
5.10.4 Mylan Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.10.5 Mylan Recent Developments
5.11 Daiichi Sankyo
5.11.1 Daiichi Sankyo Profile
5.11.2 Daiichi Sankyo Main Business
5.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Products, Services and Solutions
5.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.11.5 Daiichi Sankyo Recent Developments
5.12 TEVA
5.12.1 TEVA Profile
5.12.2 TEVA Main Business
5.12.3 TEVA Drugs for Osteoarthritis Pain Products, Services and Solutions
5.12.4 TEVA Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.12.5 TEVA Recent Developments
5.13 Almatica Pharma
5.13.1 Almatica Pharma Profile
5.13.2 Almatica Pharma Main Business
5.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
5.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.13.5 Almatica Pharma Recent Developments
5.14 Astellas Pharma
5.14.1 Astellas Pharma Profile
5.14.2 Astellas Pharma Main Business
5.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
5.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.14.5 Astellas Pharma Recent Developments
5.15 Tide Pharmaceutical
5.15.1 Tide Pharmaceutical Profile
5.15.2 Tide Pharmaceutical Main Business
5.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Products, Services and Solutions
5.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.15.5 Tide Pharmaceutical Recent Developments
5.16 Iroko Pharmaceuticals
5.16.1 Iroko Pharmaceuticals Profile
5.16.2 Iroko Pharmaceuticals Main Business
5.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Products, Services and Solutions
5.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.16.5 Iroko Pharmaceuticals Recent Developments
5.17 Hengrui Pharmaceutical
5.17.1 Hengrui Pharmaceutical Profile
5.17.2 Hengrui Pharmaceutical Main Business
5.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Products, Services and Solutions
5.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.17.5 Hengrui Pharmaceutical Recent Developments
5.18 Abiogen Pharma
5.18.1 Abiogen Pharma Profile
5.18.2 Abiogen Pharma Main Business
5.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
5.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) & (2018-2023)
5.18.5 Abiogen Pharma Recent Developments
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drugs for Osteoarthritis Pain Market Dynamics
11.1 Drugs for Osteoarthritis Pain Industry Trends
11.2 Drugs for Osteoarthritis Pain Market Drivers
11.3 Drugs for Osteoarthritis Pain Market Challenges
11.4 Drugs for Osteoarthritis Pain Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
